In a study funded by Novo-Nordisk, the Dutch pharmaceutical company that manufactures Ozempic, people treated with GLP-1 agonists ended up with an 11 percent decrease in risk for dementia
Can GLP-1 agonists be beneficial in pain and central sensitization pathways
Always price your maintenance dose, not the starter, before deciding
More research is needed to determine if the reported improvements in the reproductive parameters are directly related to the GLP1-RA or are due to weight loss, or both
Hormones, nerve function, blood vessel health, stress, and sleep all play roles
BPC-157 as a single peptide protocol is $445 per cycle, and most cycles run about one month at standard dosing